SEARCH HEALTH CONDITIONS BY ALPHABETS
Candida Esophagitis
Medications for Esophageal Candidiasis
Other names: Infection Esophagitis
About Esophageal Candidiasis: Esophageal candidiasis is a disease of the esophageal mucosae by candidiasis leading to painful and difficult swallowing.
Drugs Used to Treat Esophageal Candidiasis
The following list of medications have been used at the treatment of this condition, or in some way associated with.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Diflucan | Rx | C | N | 4 testimonials | 4.8 | ||
Generic title: fluconazole systemic Drug course: azole antifungals For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| fluconazole | Rx | C | N | 7 testimonials | 6.1 | ||
Generic title: fluconazole systemic Brand title: Diflucan Drug course: azole antifungals For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| ketoconazoleAway Tag | Rx | C | N | X | Insert review | 0.0 | |
Generic title: ketoconazole systemic Drug course: azole antifungals For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information Off-label: Yes | |||||||
| amphotericin b | Rx | B | N | Insert review | 0.0 | ||
Generic title: amphotericin b systemic Brand names: Fungizone, Amphocin Drug course: polyenes For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Vfend | Rx | D | N | Insert review | 0.0 | ||
Generic title: voriconazole systemic Drug course: azole antifungals For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| itraconazole | Rx | C | N | Insert review | 0.0 | ||
Generic title: itraconazole systemic Brand names: Sporanox, Onmel Drug course: azole antifungals For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Sporanox | Rx | C | N | Insert review | 0.0 | ||
Generic title: itraconazole systemic Drug course: azole antifungals For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| voriconazole | Rx | D | N | Insert review | 0.0 | ||
Generic title: voriconazole systemic Brand title: Vfend Drug course: azole antifungals For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| caspofungin | Rx | C | N | Insert review | 0.0 | ||
Generic title: caspofungin systemic Brand title: Cancidas Drug course: echinocandins For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| anidulafungin | Rx | B | N | Insert review | 0.0 | ||
Generic title: anidulafungin systemic Brand title: Eraxis Drug course: echinocandins For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph | |||||||
| Eraxis | Rx | B | N | Insert review | 0.0 | ||
Generic title: anidulafungin systemic Drug course: echinocandins For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Fungizone | Rx | B | N | Insert review | 0.0 | ||
Generic title: amphotericin b systemic Drug course: polyenes For users: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
| Mycamine | Rx | C | N | Insert review | 0.0 | ||
Generic title: micafungin systemic Drug course: echinocandins For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Amphocin | Rx | B | N | Insert review | 0.0 | ||
Generic title: amphotericin b systemic Drug course: polyenes For users: dose, interactions, side effects | |||||||
| Cancidas | Rx | C | N | Insert review | 0.0 | ||
Generic title: caspofungin systemic Drug course: echinocandins For users: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| micafungin | Rx | C | N | Insert review | 0.0 | ||
Generic title: micafungin systemic Brand title: Mycamine Drug course: echinocandins For users: dose, interactions, For professionals: a Z Drug Facts, AHFS DI Monograph | |||||||
| Onmel | Rx | C | N | Insert review | 0.0 | ||
Generic title: itraconazole systemic Drug course: azole antifungals For users: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Prizes | This drug might well not be approved by the FDA for treating the condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the embryo in the first trimester of pregnancy (and there`s absolutely no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated a negative effect in the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in pregnant women clearly outweigh potential rewards. |
| N | FDA has not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| Inch | includes a higher potential for misuse. Has no accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| 2 | includes a higher potential for misuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may result in severe psychological or physical dependency. |
| 3 | features a possibility for abuse less than those in programs 1 and 2 two. Features a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a minimal potential for abuse relative to those in program 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | includes a minimal potential for abuse relative to those in program 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always seek advice from your healthcare provider to ensure the information relates to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
